Some symptoms of menopause have also been described in patients with toxoplasmosis. Whether Toxoplasma gondii (T. gondii) infection has any influence on clinical manifestations of menopause is yet unknown. We sought to determine whether T. gondii exposure is associated with symptoms and signs of menopause. We performed a cross-sectional study of women attending a public health center in Durango City, Mexico. Participants were examined for the presence of anti-Toxoplasma IgG and IgM antibodies using enzyme-linked immunoassays. A questionnaire including 47 symptoms and signs potentially associated with menopause was applied. Association of seroprevalence for T. gondii with clinical characteristics of women was assessed by bivariate and multivariate analyses. Bivariate analysis showed that bouts of rapid heartbeat, breast pain, electric shock sensation, dizziness, digestive problems, low back pain, and migraine were associated with seropositivity to either IgG anti-T. gondii alone or both IgG and IgM anti-T. gondii. Breast pain was the only variable that was found to be associated with IgG seropositivity to T. gondii by multivariate analysis: (OR = 2.84; 95% CI: 1.35-5.90; P = 0.005). Our results suggest that T. gondii exposure may influence on the clinical manifestations of menopause. Results deserve further research.
Introduction
Toxoplasma gondii (T. gondii) is a parasite that is highly disseminated around the world [1] . Infection with this parasite is usually acquired by ingesting raw or undercooked meat containing T. gondii tissue cysts, consumption of food or water contaminated with T. gondii oocysts shed by cats [2] , or congenitally [3] . The clinical spectrum of T. gondii infection varies from asymptomatic to a severe disease with involvement of lymph nodes, eyes, and central nervous system [2] [3] [4] . Life-threatening toxoplasmosis may occur in immunocompromised individuals upon reactivation of latent disease [5] . Furthermore, infection with T. gondii has been linked to mental illnesses including depression [6, 7] , anxiety [7] , bipolar disorder [8] , schizophrenia [8, 9] , and cognitive impairment [10, 11] . Infection with T. gondii has also been linked to migraine [12] .
Perimenopause is a midlife neurological transition state in women [13] , and mental illnesses associated with infection with T. gondii may also occur or can be exacerbated during the perimenopausal period in women. In this regard, the incidence of migraine increases in the perimenopausal period [14, 15] , and peri-and postmenopausal women are vulnerable to the development of depression disorders [16, 17] . Furthermore, menopausal transition is also a period of increased vulnerability to cognitive declines [17] . Anxiety and/or depressive symptoms are often reported in premenopausal, perimenopausal, and postmenopausal women [18] . An exacerbation of bipolar mood symptoms and an increase in schizophrenic psychosis during perimenopause have been reported [19] .
However, it is unclear whether T. gondii infection might infl uence the pre-, peri-, and menopausal symptoms. To the best of our knowledge, the relation of T. gondii exposure and menopausal clinical manifestations has not been assessed. Women at mid-age period have clinical and epidemiological importance because of the considerable morbidity rate. Therefore, we sought to determine whether T. gondii exposure is associated with clinical characteristics of the menopausal transition and menopause in women in Durango City, Mexico.
Materials and methods

Study design and women studied
Through a cross-sectional study design, we studied 400 mid-age women who attended general consultations in a public primary healthcare center in Durango City, Mexico. Sampling was performed from August 25 to November 9, 2015. Inclusion criteria for enrollment were women aged 38 to 56 who accepted to participate in the study. Occupation and socioeconomic status were not restrictive criteria for enrollment.
Clinical data of women
Symptoms and signs of menopause in the women studied were obtained using a face-to-face questionnaire. These clinical data included presence of irregular periods, date of last period, history of hot fl ashes, red skin, bouts of rapid heartbeat, night sweats, sleep problems, memory lapses, diffi culty concentrating, depression, anxiety, mood changes, irritability, panic attacks, migraine, mental illness, itchy skin, burning mouth or tongue, allergy, breast pain, decrease in muscle power, joint pain, joint stiffness, low back pain, muscle tension, fatigue, tingling extremities, electric shock sensation, gum problems, urinary incontinence, urinary urgency, decreased libido, vaginal dryness, dyspareunia, vaginal infections, thyroid disease, changes in body odor, digestive problems, appetite disturbance, weight gain, obesity, arterial hypertension, dizziness, osteoporosis, hair loss, respiratory problems, and brittle nails.
Laboratory tests
A serum sample from each participant was obtained and stored at −20 °C until analyzed. Serum samples were analyzed for anti-T. gondii IgG antibodies with the commercially available enzyme immunoassay (EIA) kit "Toxoplasma IgG" (International Immuno-Diagnostics, Foster City, CA, USA). Anti-T. gondii IgG antibody levels were expressed as International Units (IU)/ml, and results ≥ 8 IU/ml were considered positive. Serum samples positive for anti-T. gondii IgG antibodies were further analyzed for anti-T. gondii IgM antibodies by the commercially available EIA "Toxoplasma IgM" kit (Diagnostic Automation Inc., Calabasas, CA, USA). Both assays for IgG and IgM were performed following the manufacturer's instructions.
Statistical analysis
Results were analyzed with the aid of SPSS 15.0 (SPSS Inc. Chicago, Illinois), Microsoft Excel, and Epi Info 7. For calculation of the sample size, we used: a) a reference seroprevalence of 6.1% [20] as the expected frequency for the factor under study, b) 100,000 as the population size from which the sample was selected, c) a 2.5% of confi dence limits, and d) a 95% confi dence level. The result of the sample size calculation was 351 subjects. The association of T. gondii seropositivity and the clinical characteristics of women were assessed with the Pearson's χ 2 test or the two-tailed Fisher's exact test (when values were less than 5). Variables with a P value less than 0.05 in the bivariate analysis were selected for multivariate analysis. Odds ratio (OR) and 95% confi dence interval (CI) were obtained by multivariate analysis using logistic regression with the Enter method. A P value <0.05 was considered statistically signifi cant.
Ethical aspects
This study was approved by the Ethics Committee of the General Hospital of the Secretary of Health in Durango City, Mexico. The purpose and procedures of this survey were explained to all participants. In addition, a written informed consent was obtained from each participant.
Results
Of the 400 women (mean age: 47.0 ± 5.3) studied, all but one showed at least one and up to 40 signs or symptoms of menopause. Anti-T. gondii IgG antibodies were found in 40 (10%) of the 400 women studied. Of the 40 anti-T. Table 2) .
Concerning the association of clinical data of menopause and seropositivity to both IgG and IgM anti-T. gondii, bivariate analysis showed only fi ve variables with a P value less than 0.05: bouts of rapid heartbeat, migraine, breast pain, electric shock sensation, and dizziness. Table 3 shows the correlation of selected clinical data of menopause and seropositivity to both IgG and IgM anti-T. gondii. Other clinical characteristics of menopause did not show an association with seropositivity to both IgG and IgM (P > 0.05). Prevalence of high (>150 IU/ml) IgG antibody levels was signifi cantly (P = 0.03) higher in women who reported vaginal infections (7/110; 6.4%) than in those without this clinical manifestation (6/285; 2.1%). In addition, prevalence of high IgG antibody levels was signifi cantly (P = 0.04) higher in women who reported digestive problems (13/270; 4.8%) than in those without this clinical manifestation (1/129; 0.8%). Due to a small number of cases with high IgG antibody levels and IgM seropositivity, no further regression analysis with these variables was performed. 
Discussion
To the best of our knowledge, the association between T. gondii infection and signs and symptoms of menopause has not been studied yet. Therefore, this work aimed to determine whether seropositivity to T. gondii was associated with clinical data of menopause in a sample of mid-age women in Durango City, Mexico. Remarkably, we found that women seropositive for T. gondii suffered from a signifi cantly higher mean number of signs or symptoms of menopause than seronegative women. It is not clear why seropositive women had more clinical manifestations of menopause than seronegative women did. The pathogen T. gondii has a remarkable ability to disseminate throughout the body of infected hosts to cause disease [21] . Dissemination of T. gondii to the central nervous system may lead to a number of neurological or psychiatric manifestations that resemble those observed in menopausal women. For instance, cognitive impairment [10, 11] , migraine [12] , and mood disorders [6] [7] [8] seen in patients with T. gondii infection are also considered as clinical manifestations of menopause. Perimenopause is usually linked to a reproductive transition; however, clinical manifestations of perimenopause are neurological in nature [13] . Therefore, the increased number of clinical manifestations of menopause in T. gondii infected women can be a cumulative effect of infection and the menopausal state. Intriguingly, bivariate analysis showed a number of clinical data associated with seropositivity to T. gondii. Bouts of rapid heartbeats were associated with IgG and IgM seropositivity to T. gondii. Infection with T. gondii may disseminate to heart leading to disease [22] . Therefore, T. gondii infection might have infl uenced the frequency of women with bouts of rapid heartbeats. Breast pain was also associated with IgG and IgM seropositivity to T. gondii in the women studied. The association of IgG positivity remained signifi cant following multivariate analysis. We are not aware of any report of this association in the medical literature. It is not clear why women with breast pain had a signifi cantly higher rate of T. gondii exposure than those without this clinical manifestation. Breast pain is a common symptom in women [23, 24] . Breast pain may be related to underlying diseases of the breast itself but can also arise from other diseases affecting the chest wall [25] . The etiology and optimal treatment of breast pain remain undefi ned [25] . Therefore, further research to elucidate the role of T. gondii infection in breast pain is needed. Electric shock sensation and dizziness were more frequently observed in IgG and IgM seropositive women than in seronegative women. We are not aware of any report of the association of T. gondii and electric shock sensation. The etiology of electric shock sensation in menopause remains poorly understood. Electric shock sensation is a symptom of neuropathy [26] , and T. gondii might be causing neuropathy since this parasite disseminates to the nervous system and resides in neurons of infected hosts [21] . For its part, the association of dizziness with T. gondii exposure found in the women studied confi rms previous observations in other population groups in Mexico including migrant agricultural workers [27] and people of the Huichol ethnic group [28] . The frequency of IgM seropositivity to T. gondii was higher in women with migraine than in those without this clinical feature. Migraine has been linked to perimenopause [14, 15] as well as to T. gondii infection [12] . Therefore, it is possible that infection with T. gondii could have contributed to increasing the frequency of migraine in menopausal women. High IgG levels were associated with digestive problems and vaginal infections. Digestive disorders are rarely reported in T. gondii-infected individuals. Infection with T. gondii has been linked to colitis with diarrhea [29] and abdominal pain [30] . On the other hand, it is not clear whether T. gondii infection might be involved in vaginal infections. Experimental vaginal infection with T. gondii has been demonstrated in goats [31] ; however, it is unknown whether T. gondii can cause vaginal pathology. Further research to determine the role of T. gondii in vaginal infections is needed. Our study has limitations: fi rst, a small sample size of women studied, and second, only one health center of Durango City participated. Further studies with larger samples sizes and a higher number of health centers should be conducted. This study was performed in a few months period, and it is not clear whether seasonal variation on seroprevalence might have infl uenced the results. Very little is known about the seasonal variation of T. gondii seroprevalence in humans. In a study in Serbia, researchers observed that most symptomatic acute infections occurred between October and March [32] . However, in a Chinese study, researchers did not fi nd a variation in seroprevalence of IgM anti-T. gondii with seasons in normal populations [33] .
Conclusions
This is the fi rst study that demonstrates an association of T. gondii infection with some clinical manifestations of menopause. Results suggest that women with T. gondii exposure may suffer from a broader spectrum of signs or symptoms of menopause than seronegative women. Therefore, the association of T. gondii infection with clinical manifestations of menopause deserves further research.
